Home > Income Statement > MANKIND PHARMA

MANKIND PHARMA
Revenue

    Back to Income Statement
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Net Sales ₹8,749 Cr₹7,782 Cr₹621 Cr₹58,719 Cr₹4,980 Cr

What is the latest Revenue of MANKIND PHARMA ?

The latest Revenue ratio of MANKIND PHARMA is ₹8,749 Cr based on Mar2024 Consolidated results.
Year Revenue
Mar2024₹8,749 Cr
Mar2023₹7,782 Cr
Mar2022₹621 Cr
Mar2021₹58,719 Cr
Mar2020₹4,980 Cr

How is Revenue of MANKIND PHARMA Trending?

Years Revenue % Change
Mar2024 ₹8,749 Cr
12.44
Mar2023 ₹7,782 Cr
1,152.18
Mar2022 ₹621 Cr
-98.94
Mar2021 ₹58,719 Cr
1,079.10
Mar2020 ₹4,980 Cr -

Compare Revenue of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹101,363.4 Cr 2.4% 7.1% 3.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,155.0 Cr -3.9% 3% 7.9% Stock Analytics
DIVIS LABORATORIES ₹147,295.0 Cr -5% -1.1% 71.6% Stock Analytics
CIPLA ₹116,664.0 Cr -4.4% 0.2% -1.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹107,678.0 Cr -1.6% 6.5% 26.2% Stock Analytics
DR REDDYS LABORATORIES ₹96,162.6 Cr -2.4% 2.4% -5.4% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

2.4%

7.1%

3.9%

SENSEX

-2.5%

1.9%

4.9%


You may also like the below Video Courses